Assessing a Potential Role of Host Pannexin 1 during Chlamydia trachomatis Infection

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  McKuen, Mary J ^a   Dahl, Gerhard ^a   Fields, Kenneth A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(2 CYCLOPENTYL 6,7 DICHLORO 2 METHYL 1 OXO 5 INDANYLOXY)ACETIC ACID; 5 NITRO 2(3 PHENYLPROPANOLAMINE)BENZOIC ACID; BENZOIC ACID DERIVATIVE; CARBENOXOLONE; GLIBENCLAMIDE; GLYCOPROTEIN; PANNEXIN 1; PROBENECID; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIAL SURVIVAL; CELL INCLUSION; CELLULAR PARAMETERS; CHLAMYDIASIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; ELEMENTARY BODY; GENE EXPRESSION; GENETIC TRANSFECTION; GROWTH INHIBITION; HELA CELL; INFECTIOUS FORMING UNIT; KNOCKOUT MOUSE; MICROBIAL MORPHOLOGY; MOUSE; NONHUMAN; OMCB GENE; OPMA GENE; PROTEIN FUNCTION; PROTEIN LOCALIZATION; WILD TYPE;

ANIMALS; ANTI-BACTERIAL AGENTS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CONNEXINS; HELA CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; MICE; MICE, KNOCKOUT; MICROBIAL SENSITIVITY TESTS; NERVE TISSUE PROTEINS; PROBENECID; PROTEIN TRANSPORT;

EID: 84877892710     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063732     Document Type: Article

References (50)

1. Kokes M, Valdivia RH (2012) Cell Biology of the Chlamydial Inclusion. In: Tan M, Bavoil P, editors. Intracellular Pathogens I Chlamydiales. Washington, DC: ASM Press. 170-191.
2. Abdelrahman YM, Belland RJ, (2005) The chlamydial developmental cycle. FEMS Microbiol Rev 29: 949-959.
3. Wyrick PB, (2010) Chlamydia trachomatis Persistence In Vitro: An Overview. Journal of Infectious Diseases 201: S88-S95.
4. Beatty WL, Morrison RP, Byrne GI, (1994) Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiological Reviews 58: 686-699.
5. Adams D, Gallagher K, Jajosky R, Ward J, Sharp P, et al. (2012) Summary of Notifiable Diseases-United States, 2010. MMWR 59: 1-111.
6. Batteiger BE (2012) Chlamydia infection and epidemiology. In: Tan M, Bavoil P, editors. Intracellular Pathogens I Chlamydiales. Washington, DC: ASM Press. 1-26.
7. Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, et al. (2010) Risk of Sequelae after Chlamydia trachomatis Genital Infection in Women. Journal of Infectious Diseases 201: S134-S155.
8. Stamm WE, Guinan ME, Johnson C, Starcher T, Holmes KK, et al. (1984) Effect of Treatment Regimens for Neisseria gonorrhoeae on Simultaneous Infection with Chlamydia trachomatis. New England Journal of Medicine 310: 545-549.
9. Bevan CD, Ridgway GL, Rothermel CD, (2003) Efficacy and Safety of Azithromycin as Monotherapy or Combined with Metronidazole Compared with Two Standard Multidrug Regimens for the Treatment of Acute Pelvic Inflammatory Disease. The Journal of International Medical Research 31: 45-54.
10. Haggerty CL, Ness RB, (2007) Newest Approaches to Treatment of Pelvic Inflammatory Disease: A Review of Recent Randomized Clinical Trials. Clinical Infectious Diseases 44: 953-960.
11. Toomey KE, Barnes RC (1990) Treatment of Chlamydia trachomatis genital infection. Rev Infect Dis Suppl 6: S645-655.
12. Oriel JD, Ridgway GL, Reeve P, Beckingham DC, Owen J, (1976) The Lack of Effect of Ampicillin plus Probenecid Given for Genital Infections with Neisseria gonorrhoeae on Associated Infections with Chlamydia trachomatis. Journal of Infectious Diseases 133: 568-571.
13. Di Virgilio F, Steinberg TH, Silverstein SC, (1990) Inhibition of Fura-2 sequestration and secretion with organic anion transport blockers. Cell Calcium 11: 57-62.
14. Di Virgilio F, Steinberg TH, Silverstein SC, (1989) Organic-anion transport inhibitors to facilitate measurement of cytosolic free Ca2+ and fura-2. Methods Cell Biol 31: 453-462.
15. Gollapudi S, Kim CH, Tran B-N, Sangha S, Gupta S, (1997) Probenecid reverses multidrug resistance in multidrug resistance-associated protein-overexpressing HL60/AR and H69/AR cells but not in P-glycoprotein-overexpressing HL60/Tax and P388/ADR cells. Cancer Chemotherapy and Pharmacology 40: 150-158.
16. Silverman W, Locovei S, Dahl G, (2008) Probenecid, a gout remedy, inhibits pannexin 1 channels. American Journal of Physiology- Cell Physiology 295: C761-C767.
17. Boassa D, Ambrosi C, Qiu F, Dahl G, Gaietta G, et al. (2007) Pannexin1 Channels Contain a Glycosylation Site That Targets the Hexamer to the Plasma Membrane. Journal of Biological Chemistry 282: 31733-31743.
18. Penuela S, Gehi R, Laird DW, (2013) The biochemistry and function of pannexin channels. Biochimica et Biophysica Acta (BBA)- Biomembranes. 1828: 15-22.
19. Dahl G, Keane RW, (2012) Pannexin: From discovery to bedside in 11±4 years? Brain Research. 1487: 150-159.
20. Barbe MT, Monyer H, Bruzzone R, (2006) Cell-Cell Communication Beyond Connexins: The Pannexin Channels. Physiology 21: 103-114.
21. Bao L, Locovei S, Dahl G, (2004) Pannexin membrane channels are mechanosensitive conduits for ATP. FEBS Letters 572: 65-68.
22. Locovei S, Bao L, Dahl G, (2006) Pannexin 1 in erythrocytes: Function without a gap. Proceedings of the National Academy of Sciences 103: 7655-7659.
23. Locovei S, Wang J, Dahl G, (2006) Activation of pannexin 1 channels by ATP through P2Y receptors and by cytoplasmic calcium. FEBS Letters 580: 239-244.
24. Suadicani SO, Iglesias R, Wang J, Dahl G, Spray DC, et al. (2012) ATP signaling is deficient in cultured pannexin1-null mouse astrocytes. Glia 60: 1106-1116.
25. Pelegrin P, Surprenant A, (2006) Pannexin-1 mediates large pore formation and interleukin-1[beta] release by the ATP-gated P2X7 receptor. EMBO J 25: 5071-5082.
26. Baroja-Mazo A, Barberà-Cremades M, Pelegrín P, (2013) The participation of plasma membrane hemichannels to purinergic signaling. Biochimica et Biophysica Acta (BBA)- Biomembranes 1828: 79-93.
27. Kanneganti T-D, Lamkanfi M, Kim Y-G, Chen G, Park J-H, et al. (2007) Pannexin-1-Mediated Recognition of Bacterial Molecules Activates the Cryopyrin Inflammasome Independent of Toll-like Receptor Signaling. Immunity 26: 433-443.
28. Iglesias R, Locovei S, Roque A, Alberto AP, Dahl G, et al. (2008) P2X7 receptor-Pannexin1 complex: pharmacology and signaling. American Journal of Physiology- Cell Physiology 295: C752-C760.
29. Locovei S, Scemes E, Qiu F, Spray DC, Dahl G, (2007) Pannexin1 is part of the pore forming unit of the P2X7 receptor death complex. FEBS Letters 581: 483-488.
30. Silverman WR, de Rivero Vaccari JP, Locovei S, Qiu F, Carlsson SK, et al. (2009) The Pannexin 1 Channel Activates the Inflammasome in Neurons and Astrocytes. Journal of Biological Chemistry 284: 18143-18151.
31. Abdul-Sater AA, Saïd-Sadier N, Padilla EV, Ojcius DM, (2010) Chlamydial infection of monocytes stimulates IL-1β secretion through activation of the NLRP3 inflammasome. Microbes and Infection 12: 652-661.
32. Abdul-Sater AA, Koo E, Häcker G, Ojcius DM, (2009) Inflammasome-dependent Caspase-1 Activation in Cervical Epithelial Cells Stimulates Growth of the Intracellular Pathogen Chlamydia trachomatis. Journal of Biological Chemistry 284: 26789-26796.
33. Shimada K, Crother TR, Karlin J, Chen S, Chiba N, et al. (2011) Caspase-1 Dependent IL-1β Secretion Is Critical for Host Defense in a Mouse Model of Chlamydia pneumoniae Lung Infection. PLoS ONE 6: e21477.
34. Thacker JD, Balin BJ, Appelt DM, Sassi-Gaha S, Purohit M, et al. (2012) NLRP3 inflammasone is a target for development of broad-spectrum anti-infective drugs. Antimicrob Agents Chemother 56: 1921-1930.
35. Nagarajan UM, Sikes JD, Yeruva L, Prantner D, (2012) Significant Role of IL-1 Signaling, but Limited Role of Inflammasome Activation, in Oviduct Pathology during Chlamydia muridarum Genital Infection. The Journal of Immunology 188: 2866-2875.
36. Shaw EI, Dooley CA, Fischer ER, Scidmore MA, Fields KA, et al. (2000) Three temporal classes of gene expression during the Chlamydia trachomatis developmental cycle. Mol Microbiol 37: 913-925.
37. Ma W, Hui H, Pelegrin P, Surprenant A, (2009) Pharmacological Characterization of Pannexin-1 Currents Expressed in Mammalian Cells. Journal of Pharmacology and Experimental Therapeutics 328: 409-418.
38. Qiu F, Wang J, Spray DC, Scemes E, Dahl G, (2011) Two non-vesicular ATP release pathways in the mouse erythrocyte membrane. FEBS Letters 585: 3430-3435.
39. Rockey DD, Scidmore MA, Bannantine JP, Brown WJ, (2002) Proteins in the chlamydial inclusion membrane. Microbes Infect 4: 333-340.
40. Keeling DJ, Taylor AG, Smith PL, (1991) Effects of NPPB (5-nitro-2-(3-phenylpropylamino)benzoic acid) on chloride transport in intestinal tissues and the T84 cell line. Biochimica et Biophysica Acta (BBA)- General Subjects 1115: 42-48.
41. Cox JV, Naher N, Abdelrahman YM, Belland RJ, (2012) Host HDL biogenesis machinery is recruited to the inclusion of Chlamydia trachomatis-infected cells and regulates chlamydial growth. Cell Microbiol 14: 1497-1512.
42. Sweet DH, (2005) Organic anion transporter (Slc22a) family members as mediators of toxicity. Toxicology and Applied Pharmacology 204: 198-215.
43. Balakrishnan A, Wang L, Li X, Ohman-Strickland P, Malatesta P, et al. (2009) Inhibition of chlamydial infection in the genital tract of female mice by topical application of a peptide deformylase inhibitor. Microbiological Research 164: 338-346.
44. Bao X, Pachikara ND, Oey CB, Balakrishnan A, Westblade LF, et al. (2011) Non-coding nucleotides and amino acids near the active site regulate peptide deformylase expression and inhibitor susceptibility in Chlamydia trachomatis. Microbiology 157: 2569-2581.
45. Heinzen RA, Hackstadt T, (1997) The Chlamydia trachomatis parasitophorous vacuolar membrane is not passively permeable to low-molecular-weight compounds. Infect Immun 65: 1088-1094.
46. Grieshaber S, Swanson JA, Hackstadt T (2002) Determination of the physical environment within the Chlamydia trachomatis inclusion using ion-selective ratiometric probes. Cell Microbiol.
47. Caldwell HD, Kromhout J, Schachter J, (1981) Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun 31: 1161-1176.
48. Hackstadt T, Scidmore MA, Rockey DD, (1995) Lipid metabolism in Chlamydia trachomatis-infected cells: directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion. Proc Natl Acad Sci U S A 92: 4877-4881.
49. Furness G, Graham DM, Reeve P, (1960) The titration of trachoma and inclusion blennorrhoea viruses in cell cultures. J Gen Microbiol 23: 613-619.
50. Scidmore-Carlson MA, Shaw EI, Dooley CA, Fischer ER, Hackstadt T, (1999) Identification and characterization of a Chlamydia trachomatis early operon encoding four novel inclusion membrane proteins. Mol Microbiol 33: 753-765.